These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 311767)

  • 1. Natural killer activity in patients with acute myelocytic leukemia.
    Stupp Y; Rosenkovitch E; Izak G
    Isr J Med Sci; 1978 Dec; 14(12):1212-5. PubMed ID: 311767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased natural killer cell activity in children with untreated acute leukemia.
    Nasrallah AG; Miale TD
    Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibody-dependent cytotoxicity of lymphocytes in acute myeloblastic leukemia and chronic myelocytic leukemia].
    Tishchenko LM; Guseva SA
    Eksp Onkol; 1987; 9(2):66-7. PubMed ID: 3472877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusion.
    Stein M; Feldman E; Seiter K; Chiao JW; Goff H; Baskind P; Beer M; Ahmed T
    Bone Marrow Transplant; 1999 Nov; 24(10):1073-7. PubMed ID: 10578157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying the biological response to acute myeloid leukemia I. BCG, allogeneic leukemic cells and spontaneous cytotoxicity.
    Arends-Merino A; Sjögren AM; Reizenstein P
    Anticancer Res; 1983; 3(4):239-41. PubMed ID: 6576728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
    Inada M; Okawa H; Suzuki M; Yata J
    Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spontaneous lymphocyte-mediated cytotoxicity and antibody-dependent cell cytotoxicity of human effector cells].
    Thränhardt H; Soeberdt R; König A; Zintl F; Metz O; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):831-42. PubMed ID: 6200394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia.
    Thorén FB; Romero AI; Brune M; Hellstrand K
    Expert Opin Biol Ther; 2009 Sep; 9(9):1217-23. PubMed ID: 19653866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission.
    Suzuki M
    Jpn J Clin Oncol; 1984 Mar; 14(1):31-40. PubMed ID: 6231391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
    Sharma B; Vaziri ND
    Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody-dependent cellular cytotoxicity (AAZZ) against leukemia cells--K-cell activity of human leukocytes].
    Thränhardt H; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):824-40. PubMed ID: 6162750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
    Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
    Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?
    Aswald JM; Wang XH; Aswald S; Lutynski A; Minden MD; Messner HA; Keating A
    Cytometry B Clin Cytom; 2006 Nov; 70(6):379-90. PubMed ID: 16977635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some studies on natural killer cells in man.
    Lotzová E; McCredie KB; Maroun JA; Dicke KA; Freireich EJ
    Transplant Proc; 1979 Jun; 11(2):1390-2. PubMed ID: 314185
    [No Abstract]   [Full Text] [Related]  

  • 18. Deficiency of antibody-dependent cellular cytotoxicity and mitogen-induced cellular cytotoxicity effector cell function in patients with acute myelogenous leukemia in remission.
    Zighelboim J
    Cancer Res; 1979 Sep; 39(9):3357-62. PubMed ID: 314332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human nonspecific killer cells].
    Thränhardt H; Zintl F; Milleck J; Jantscheff P; Hermann J; Fuchs D; Voigt P; Metz O; Löbe LP; Mohr F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):390-407. PubMed ID: 6182059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
    Teichmann JV; Ludwig WD; Thiel E
    Nat Immun; 1992; 11(3):117-32. PubMed ID: 1392400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.